Sector Gamma ASA
Latest statistics and disclosures from Sector Gamma As's latest quarterly 13F-HR filing:
- Top 5 stock holdings are PFE, MDT, MRK, BMY, BDX, and represent 33.34% of Sector Gamma As's stock portfolio.
- Added to shares of these 10 stocks: MRK (+$10M), PFE (+$8.5M), BMY (+$7.9M), MDT (+$7.6M), VTRS (+$6.6M), OGN (+$5.8M), AMGN, ICLR, KURA, BIIB.
- Started 6 new stock positions in VTRS, OGN, ICLR, KURA, SNDX, CERT.
- Reduced shares in these 9 stocks: QGEN (-$5.6M), TMO, ELV, TGTX, , CAH, IONS, BNTX, CVS.
- Sold out of its positions in THC, TGTX, QGEN.
- Sector Gamma As was a net buyer of stock by $85M.
- Sector Gamma As has $403M in assets under management (AUM), dropping by 31.83%.
- Central Index Key (CIK): 0001475373
Tip: Access up to 7 years of quarterly data
Positions held by Sector Gamma ASA consolidated in one spreadsheet with up to 7 years of data
Download as csvPortfolio Holdings for Sector Gamma As
Sector Gamma As holds 41 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Pfizer (PFE) | 7.9 | $32M | +36% | 1.3M | 25.48 |
|
| Medtronic SHS (MDT) | 7.2 | $29M | +35% | 303k | 95.24 |
|
| Merck & Co (MRK) | 6.7 | $27M | +59% | 323k | 83.93 |
|
| Bristol Myers Squibb (BMY) | 6.5 | $26M | +43% | 581k | 45.10 |
|
| Becton, Dickinson and (BDX) | 5.1 | $20M | +11% | 109k | 187.17 |
|
| Ionis Pharmaceuticals (IONS) | 4.4 | $18M | -5% | 271k | 65.42 |
|
| Incyte Corporation (INCY) | 4.3 | $17M | 205k | 84.81 |
|
|
| Amgen (AMGN) | 4.3 | $17M | +39% | 62k | 282.20 |
|
| Gilead Sciences (GILD) | 4.1 | $16M | +15% | 147k | 111.00 |
|
| CVS Caremark Corporation (CVS) | 2.9 | $12M | -4% | 156k | 75.39 |
|
| Zimmer Holdings (ZBH) | 2.8 | $11M | +28% | 114k | 98.50 |
|
| Biogen Idec (BIIB) | 2.6 | $11M | +49% | 76k | 140.08 |
|
| BioMarin Pharmaceutical (BMRN) | 2.4 | $9.5M | +43% | 176k | 54.16 |
|
| Cardinal Health (CAH) | 2.3 | $9.3M | -9% | 60k | 156.96 |
|
| Thermo Fisher Scientific (TMO) | 2.2 | $8.9M | -27% | 18k | 485.02 |
|
| Baxter International (BAX) | 2.2 | $8.7M | +42% | 382k | 22.77 |
|
| Ge Healthcare Technologies I Common Stock (GEHC) | 2.1 | $8.4M | +50% | 111k | 75.10 |
|
| Bruker Corporation (BRKR) | 2.0 | $8.2M | +28% | 251k | 32.49 |
|
| Centene Corporation (CNC) | 1.9 | $7.6M | +40% | 213k | 35.68 |
|
| Labcorp Holdings Com Shs (LH) | 1.8 | $7.5M | +33% | 26k | 287.06 |
|
| Ptc Therapeutics I (PTCT) | 1.8 | $7.2M | +28% | 118k | 61.37 |
|
| Viatris (VTRS) | 1.6 | $6.6M | NEW | 669k | 9.90 |
|
| Bio Rad Labs Cl A (BIO) | 1.6 | $6.4M | +28% | 23k | 280.39 |
|
| Humana (HUM) | 1.5 | $6.2M | 24k | 260.17 |
|
|
| Elanco Animal Health (ELAN) | 1.5 | $6.2M | +5% | 307k | 20.14 |
|
| Avantor (AVTR) | 1.5 | $6.0M | +28% | 477k | 12.48 |
|
| Organon & Co Common Stock (OGN) | 1.4 | $5.8M | NEW | 544k | 10.68 |
|
| Edwards Lifesciences (EW) | 1.4 | $5.7M | +73% | 73k | 77.77 |
|
| Dex (DXCM) | 1.3 | $5.2M | +53% | 77k | 67.29 |
|
| Ascendis Pharma A/s Sponsored Adr (ASND) | 1.2 | $4.8M | +43% | 24k | 198.81 |
|
| Hca Holdings (HCA) | 1.2 | $4.6M | +36% | 11k | 426.20 |
|
| Icon SHS (ICLR) | 1.1 | $4.4M | NEW | 25k | 175.00 |
|
| Solventum Corp Com Shs (SOLV) | 1.1 | $4.3M | +55% | 59k | 73.00 |
|
| Kura Oncology (KURA) | 1.0 | $3.9M | NEW | 438k | 8.85 |
|
| Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 0.8 | $3.3M | +28% | 64k | 51.29 |
|
| Tandem Diabetes Care Com New (TNDM) | 0.8 | $3.3M | +28% | 270k | 12.14 |
|
| Syndax Pharmaceuticals (SNDX) | 0.8 | $3.2M | NEW | 211k | 15.38 |
|
| Anthem (ELV) | 0.8 | $3.1M | -48% | 9.6k | 323.12 |
|
| Certara Ord (CERT) | 0.7 | $2.8M | NEW | 231k | 12.22 |
|
| Biontech Se Sponsored Ads (BNTX) | 0.7 | $2.7M | -25% | 28k | 98.62 |
|
| Arcellx Common Stock (ACLX) | 0.7 | $2.6M | +28% | 32k | 82.10 |
|
Past Filings by Sector Gamma As
SEC 13F filings are viewable for Sector Gamma As going back to 2010
- Sector Gamma As 2025 Q3 filed Oct. 31, 2025
- Sector Gamma As 2025 Q2 filed July 31, 2025
- Sector Gamma As 2025 Q1 filed May 13, 2025
- Sector Gamma As 2024 Q4 filed Feb. 11, 2025
- Sector Gamma As 2024 Q3 filed Nov. 13, 2024
- Sector Gamma As 2024 Q2 filed Aug. 9, 2024
- Sector Gamma As 2024 Q1 filed May 8, 2024
- Sector Gamma As 2023 Q4 filed Feb. 5, 2024
- Sector Gamma As 2023 Q3 filed Nov. 6, 2023
- Sector Gamma As 2023 Q2 filed Aug. 9, 2023
- Sector Gamma As 2023 Q1 filed May 12, 2023
- Sector Gamma As 2022 Q4 restated filed Feb. 8, 2023
- Sector Gamma As 2022 Q4 filed Feb. 7, 2023
- Sector Gamma As 2022 Q3 filed Nov. 9, 2022
- Sector Gamma As 2022 Q2 filed Aug. 5, 2022
- Sector Gamma As 2022 Q1 filed May 6, 2022